Among bisacodyl-based products on the international market, Dulcolax is one of the more broadly distributed brands, registered in 49 countries. Its active ingredient is bisacodyl, classified within the laxative category, and the brand has become a familiar reference point for travellers looking for a comparable product abroad.
Bisacodyl is prescribed and used for the short-term management of constipation, for bowel preparation in connection with surgery or certain diagnostic procedures, and in some markets for the management of proctitis. The structured indication list further down this page details the registered uses recognised across the regulatory regimes where Dulcolax is sold, which can vary from one country to another.
Because Dulcolax has such a wide international footprint, expatriates and travellers often encounter the same brand abroad, sometimes alongside locally produced bisacodyl generics. Markets where the brand is registered include Brazil, France, China, Denmark, and Canada, but packaging, strength conventions, and whether the product sits on the open shelf or behind a pharmacy counter differ noticeably between jurisdictions. A local pharmacist is generally the quickest route to confirming whether a given bisacodyl product on the shelf corresponds to what the reader knows from home.
Other medications in the broader laxative class, working through different mechanisms, are also distributed worldwide under various brand names — a pharmacist familiar with the local formulary can identify regional options where bisacodyl itself is not the preferred choice. Any decision about beginning, continuing, or substituting a laxative regimen should sit with a healthcare provider who knows the individual circumstances.
December 2017
Aventis Pharma Limited
One Onslow Street
Guildford
Surrey
GU1 4YS
United Kingdom
Trading as:
Sanofi
One Onslow Street
Guildford
Surrey
GU1 4YS
United Kingdom
Do not store above 25°C
In order to protect from light, keep the blister in the outer carton.
DULCOLAX 10 mg Suppositories are presented in aluminium foil blister strips coated with polyethylene.
Pack sizes of 6, 10, 12, 20, 50 and 200.
Not all pack sizes may be marketed.
PL 04425/0716
None stated.
22 January 1992 / 25 February 2005
Dulcolax (bisacodyl) is used for the short-term management of constipation, for bowel preparation in the context of surgery or diagnostic procedures, and in some markets for the management of proctitis. It belongs to the laxative class. The structured indication block further down this page lists the registered uses recognised by the regulators in the countries where the brand is marketed.
The active ingredient is bisacodyl, classified as a laxative. Bisacodyl is the same molecule whether it appears under the Dulcolax label or under a generic name, and it circulates internationally under a number of different brand names. In some countries it is available without a prescription, while in others it sits behind the pharmacy counter, depending on local regulation.
Dulcolax (bisacodyl) is registered in 49 countries spread across Europe, the Americas, and Asia. Representative markets include Brazil, France, China, Canada, Denmark, the Czech Republic, and Ecuador. If your country is not in the list shown on this page, a local pharmacist can usually confirm whether bisacodyl is available locally under this brand or under another name.
Bisacodyl is sold under several brand names worldwide and is also available as a generic in many markets. Other medications within the broader laxative category exist as well, although they work through different mechanisms and are not freely interchangeable. To identify a local bisacodyl-containing product, search the active ingredient on Pill2Trip or ask a pharmacist in your country about suitable options.
Yes. Although bisacodyl products are sold over the counter in some jurisdictions, persistent constipation, recurrent symptoms, or use in the context of surgery or another medical condition should be discussed with a healthcare provider. Prescription rules and packaging differ across countries, which matters for travellers and people relocating internationally. Decisions about starting, continuing, or stopping a laxative belong with a clinician familiar with the individual case.
